223 filings
Page 2 of 12
8-K
tcw5 dkh90
7 Aug 23
Other Events
7:40am
8-K
jrjxed
3 Aug 23
Collegium Reports Record 1H’23 Net Revenue of $280.3 Million, Up 35% Year-over-Year
4:03pm
8-K
ss3 uchoj
19 May 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
okxr5bltdq92
4 May 23
Collegium Reports First Quarter 2023 Financial Results
4:01pm
ARS
dqy6zprf ybgn3j
11 Apr 23
Annual report to shareholders
4:04pm
8-K
pg4 9k1tpy2z
23 Feb 23
Collegium Reports Fourth Quarter and Full-Year 2022 Financial Results
4:01pm
8-K
dlimh7c6fg0oixu2
13 Feb 23
Collegium Pharmaceutical, Inc. Prices Upsized $210.0 Million Convertible Senior Notes Offering
4:05pm
8-K
ctwfg81tkq4dqewd2v
6 Feb 23
Collegium Announces Fourth Quarter and Full Year 2022 Preliminary Financial Results
4:14pm
8-K
97skn xkk
4 Jan 23
Regulation FD Disclosure
8:04am
8-K
55m0sl5v9i80ph14w
22 Dec 22
Appeals Court Affirms Validity of Collegium’s Belbuca® Patents
8:04am
8-K
qo93tp
3 Nov 22
Collegium Reports Third Quarter 2022 Financial Results
4:01pm
S-8
rowte 2f6d1ytz2
11 Aug 22
Registration of securities for employees
4:04pm
8-K
z6c46co8qabo
4 Aug 22
Collegium Reports Second Quarter 2022 Financial Results
4:01pm
8-K
1zcgbat1h5 5qvw9b
23 May 22
Submission of Matters to a Vote of Security Holders
4:05pm